Clinical Trial Update: Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter [Phase 2]

View source ↗

Summary

Phase 2 study evaluating modified release rhTSH for safety and effectiveness in multinodular goiter has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multinodular Goiter

Drugs mentioned

• Modified-release rhTSH (recombinant human thyroid-stimulating hormone)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Multinodular Goiter | Phase 2 | Status: COMPLETED